Rhenman & Partners Asset Management Ab Edwards Lifesciences Corp Transaction History
Rhenman & Partners Asset Management Ab
- $854 Million
- Q3 2025
A detailed history of Rhenman & Partners Asset Management Ab transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 155,000 shares of EW stock, worth $13.4 Million. This represents 1.41% of its overall portfolio holdings.
Number of Shares
155,000
Previous 55,000
181.82%
Holding current value
$13.4 Million
Previous $4.3 Million
180.26%
% of portfolio
1.41%
Previous 0.56%
Shares
26 transactions
Others Institutions Holding EW
# of Institutions
1,472Shares Held
468MCall Options Held
3.46MPut Options Held
4.07M-
Vanguard Group Inc Valley Forge, PA70.4MShares$6.07 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$4.4 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.6MShares$2.21 Billion0.07% of portfolio
-
Jpmorgan Chase & CO New York, NY25.1MShares$2.16 Billion0.13% of portfolio
-
Wellington Management Group LLP Boston, MA20.8MShares$1.8 Billion0.3% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $53.4B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...